Patent Assignment
Reel/Frame 069987/0040
Change of Name
Recorded: 2025-01-22
Pages: 4
Assignor
OCUPHIRE PHARMA, INC.
Executed: 2024-10-22
Assignee
OPUS GENETICS, INC.
37000 GRAND RIVER AVE., SUITE 120, FARMINGTON HILLS, MICHIGAN, 48335
Covered Properties
(3)
Methods and Compositions for Treatment of Diabetic Retinopathy and Related Conditions
Application:
18/288,435 →
Publication:
US 2024/0216315
Salts and Esters of APX3330 and Therapeutic Uses Thereof
Salts and Esters of APX3330 and Therapeutic Uses Thereof
Application:
18/367,631 →
Publication:
US 2024/0101505
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 7, 2024
From: ONICIU, DANIELA CARMEN
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067655/0821 →
Assignment of Assignor's Interest
Jun 7, 2024
From: LUNGAN, MARIA-ANDREEA; PATRASCU, ANDREI-ALUNEL; MANTA, CORINA-MIHAELA
To: SARA PHARM SOLUTIONS S.R.L.
Reel/Frame 067655/0981 →
Assignment of Assignor's Interest
Jun 7, 2024
From: SARA PHARM SOLUTIONS S.R.L.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067656/0199 →
Assignment of Assignor's Interest
Jun 7, 2024
From: CARESTIA, ANTHONY; HOUSLEY, JON
To: CAMBREX HIGH POINT, INC.
Reel/Frame 067656/0848 →
Assignment of Assignor's Interest
Jun 7, 2024
From: CAMBREX HIGH POINT, INC.
To: OCUPHIRE PHARMA, INC.
Reel/Frame 067657/0131 →
Assignment of Assignor's Interest
Jan 22, 2025
From: SOOCH, MINA; CHARIZANIS, KONSTANTINOS; KELLEY, MARK R.; MESSMANN, RICHARD ADAM
To: OCUPHIRE PHARMA, INC.
Reel/Frame 069971/0879 →
Security Interest
Apr 21, 2026
From: OPUS GENETICS, INC.
To: OPCM SA LLC, AS PURCHASER AGENT FOR THE SECURED PARTIES
Reel/Frame 075478/0138 →
Assignment of Assignor's Interest
Aug 5, 2026
From: OPUS GENETICS, INC.
To: APEXIAN PHARMACEUTICALS, INC.
Reel/Frame 075531/0886 →